Penumbra (PEN) Financial Analysis & Valuation | Quarter Chart
Penumbra (PEN)
PENPrice: $315.46
Fair Value: 🔒
🔒score
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penu... more
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and... more
Description
Shares
| Market Cap | $12.41B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Adam Elsesser |
| IPO Date | 2015-09-18 | CAGR | 0.26% |
| Employees | 4,600 | Website | www.penumbrainc.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
PEN chart loading...
Fundamentals
Technicals
| Enterprise Value | $12.35B | P/E Ratio | 82.37 |
| Forward P/E | 50.29 | PEG Ratio | -4.04 |
| P/S Ratio | 8.19 | P/B Ratio | 8.07 |
| P/CF Ratio | 42.98 | P/FCF Ratio | 55.97 |
| EPS | $3.83 | EPS Growth 1Y | 309.43% |
| EPS Growth 3Y | 2575.71% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 17.27% | Gross Margin | 0.67% |
| Operating Margin | 0.13% | Profit Margin | 0.12% |
| ROE | 0.12% | ROA | 0.09% |
| ROCE | 0.11% | Current Ratio | 6.02 |
| Quick Ratio | 3.95 | Cash Ratio | 1.14 |
| Debt/Equity | 0.15 | Interest Coverage | 284.83 |
| Altman Z Score | 19.52 | Piotroski Score | 6 |